Mucoadhesive carriers for oral drug delivery

R Kumar, T Islam, M Nurunnabi - Journal of Controlled Release, 2022 - Elsevier
Among the various dosage forms, oral medicine has extensive benefits including ease of
administration and patients' compliance, over injectable, suppositories, ocular and nasal …

Biotechnology, Bioengineering and Applications of Bacillus Nattokinase

L Yuan, C Liangqi, T Xiyu, L Jinyao - Biomolecules, 2022 - mdpi.com
Thrombosis has threatened human health in past decades. Bacillus nattokinase is a
potential low-cost thrombolytic drug without side-effects and has been introduced into the …

Nattokinase attenuates bisphenol A or gamma irradiation-mediated hepatic and neural toxicity by activation of Nrf2 and suppression of inflammatory mediators in rats

MMM Elbakry, SZ Mansour, H Helal… - … Science and Pollution …, 2022 - Springer
Nattokinase (NK), a protease enzyme produced by Bacillus subtilis, has various biological
effects such as lipid-lowering activity, antihypertensive, antiplatelet/anticoagulant, and …

Recent advances in nattokinase-enriched fermented soybean Foods: A review

D Li, L Hou, M Hu, Y Gao, Z Tian, B Fan, S Li, F Wang - Foods, 2022 - mdpi.com
With the dramatic increase in mortality of cardiovascular diseases (CVDs) caused by
thrombus, this has sparked an interest in seeking more effective thrombolytic drugs or …

Research progress on the utilisation of embedding technology and suitable delivery systems for improving the bioavailability of nattokinase: a review

X Zhou, L Liu, X Zeng - Food Structure, 2021 - Elsevier
Nattokinase is a thrombolytic drug that is more advantageous than urokinase, streptokinase,
and tissue plasminogen activator because of its low price, high efficiency, and nontoxic side …

Production, purification, and functional properties of microbial fibrinolytic enzymes produced by microorganism obtained from soy-based fermented foods …

M Yao, Y Yang, J Fan, C Ma, X Liu… - Critical Reviews in …, 2024 - Taylor & Francis
Abstract According to the World Health Organization, cardiovascular disease (CVD) has
become a major cause of chronic illness around the globe. It has been reported that soy …

Characterization of a Nattokinase from the Newly Isolated Bile Salt-Resistant Bacillus mojavensis LY-06

Y Li, X Tang, L Chen, X Xu, J Li - Foods, 2022 - mdpi.com
Nattokinase is a potential new thrombolytic drug because of its strong thrombolytic effect,
high safety, and low cost. However, there is no research reporting on bile salt-tolerant …

[HTML][HTML] Screening of a Bacillus subtilis strain producing both nattokinase and milk-clotting enzyme and its application in fermented milk with thrombolytic activity

X Zhang, Y Tong, J Wang, X Lyu, R Yang - Journal of Dairy Science, 2021 - Elsevier
Bacillus subtilis is a generally recognized as safe probiotic, which is used as a starter for
natto fermentation. Natto is a functional food with antithrombus function due to nattokinase …

[HTML][HTML] Biofunctional chitosan–biopolymer composites for biomedical applications

Y Guo, D Qiao, S Zhao, P Liu, F Xie, B Zhang - Materials Science and …, 2024 - Elsevier
In light of escalating biomedical demands across diverse diseases, there arises a pressing
need for the development of sophisticated biocompatible materials exhibiting augmented …

Biodegradable nanoparticles prepared from chitosan and casein for delivery of bioactive polysaccharides

C Lin, FY Hsu, WT Lin, CY Cha, YC Ho, FL Mi - Polymers, 2022 - mdpi.com
Ophiopogon japonicus polysaccharides (OJPs) have great anti-inflammation and
immunomodulatory abilities. However, the low bioavailability of OJPs reduces its …